APO Research
Talk to an analyst

APO RESEARCH · REPORT

Valsartan-Hydrochlorothiazide

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Valsartan-Hydrochlorothiazide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025194 pages

Choose your research edition.

Industry ResearchValsartan-Hydrochlorothiazide Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Valsartan-Hydrochlorothiazide Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Valsartan-Hydrochlorothiazide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valsartan-Hydrochlorothiazide Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Valsartan-Hydrochlorothiazide Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Valsartan-Hydrochlorothiazide market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Valsartan-Hydrochlorothiazide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Valsartan-Hydrochlorothiazide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Valsartan-Hydrochlorothiazide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Valsartan-Hydrochlorothiazide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Valsartan-Hydrochlorothiazide include Teva, Novartis, Mylan, Huaren Pharmaceutical, Zhejiang Huahai Pharmaceutical, Torrent Pharmaceuticals, Par Pharmaceutical, MACLEODS and Lupin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Valsartan-Hydrochlorothiazide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Valsartan-Hydrochlorothiazide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Valsartan-Hydrochlorothiazide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Valsartan-Hydrochlorothiazide market size, projected growth trends, production technologies, key applications, and end-use industries.

Valsartan-Hydrochlorothiazide Segment by Company

Teva

Novartis

Mylan

Huaren Pharmaceutical

Zhejiang Huahai Pharmaceutical

Torrent Pharmaceuticals

Par Pharmaceutical

MACLEODS

Lupin

Cisen Pharmaceutical

Chongqing Conquer Pharmaceutical

Beijing Second Pharmaceutical

Aurobindo Pharma

APOTEX

Alembic Pharmaceuticals

Valsartan-Hydrochlorothiazide Segment by Type

Tablet

Capsule

Valsartan-Hydrochlorothiazide Segment by Application

Hospital

Drug Store

Valsartan-Hydrochlorothiazide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valsartan-Hydrochlorothiazide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valsartan-Hydrochlorothiazide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valsartan-Hydrochlorothiazide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Valsartan-Hydrochlorothiazide market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Valsartan-Hydrochlorothiazide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Valsartan-Hydrochlorothiazide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Valsartan-Hydrochlorothiazide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Valsartan-Hydrochlorothiazide Industry Trends Table 2. Valsartan-Hydrochlorothiazide Industry Drivers Table 3. Valsartan-Hydrochlorothiazide Industry Opportunities and Challenges Table 4. Valsartan-Hydrochlorothiazide Industry Restraints Table 5. Global Valsartan-Hydrochlorothiazide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Valsartan-Hydrochlorothiazide Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Valsartan-Hydrochlorothiazide Sales Market Share by Manufacturers Table 9. Global Valsartan-Hydrochlorothiazide Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Valsartan-Hydrochlorothiazide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Valsartan-Hydrochlorothiazide Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Valsartan-Hydrochlorothiazide Manufacturers, Product Type & Application Table 13. Global Valsartan-Hydrochlorothiazide Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Valsartan-Hydrochlorothiazide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablet Table 17. Major Manufacturers of Capsule Table 18. Global Valsartan-Hydrochlorothiazide Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Valsartan-Hydrochlorothiazide Sales by Type (2021-2026) & (K Units) Table 20. Global Valsartan-Hydrochlorothiazide Sales by Type (2027-2032) & (K Units) Table 21. Global Valsartan-Hydrochlorothiazide Sales Market Share by Type (2021-2026) Table 22. Global Valsartan-Hydrochlorothiazide Sales Market Share by Type (2027-2032) Table 23. Global Valsartan-Hydrochlorothiazide Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Valsartan-Hydrochlorothiazide Revenue by Type (2021-2026) & (K Units) Table 25. Global Valsartan-Hydrochlorothiazide Revenue by Type (2027-2032) & (K Units) Table 26. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Type (2021-2026) Table 27. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Drug Store Table 30. Global Valsartan-Hydrochlorothiazide Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Valsartan-Hydrochlorothiazide Sales by Application (2021-2026) & (K Units) Table 32. Global Valsartan-Hydrochlorothiazide Sales by Application (2027-2032) & (K Units) Table 33. Global Valsartan-Hydrochlorothiazide Sales Market Share by Application (2021-2026) Table 34. Global Valsartan-Hydrochlorothiazide Sales Market Share by Application (2027-2032) Table 35. Global Valsartan-Hydrochlorothiazide Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Valsartan-Hydrochlorothiazide Revenue by Application (2021-2026) & (K Units) Table 37. Global Valsartan-Hydrochlorothiazide Revenue by Application (2027-2032) & (K Units) Table 38. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Application (2021-2026) Table 39. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Application (2027-2032) Table 40. Global Valsartan-Hydrochlorothiazide Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Valsartan-Hydrochlorothiazide Sales by Region (2021-2026) & (K Units) Table 42. Global Valsartan-Hydrochlorothiazide Sales Market Share by Region (2021-2026) Table 43. Global Valsartan-Hydrochlorothiazide Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Valsartan-Hydrochlorothiazide Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Valsartan-Hydrochlorothiazide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Valsartan-Hydrochlorothiazide Sales by Country (2021-2026) & (K Units) Table 47. North America Valsartan-Hydrochlorothiazide Sales by Country (2027-2032) & (K Units) Table 48. Europe Valsartan-Hydrochlorothiazide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Valsartan-Hydrochlorothiazide Sales by Country (2021-2026) & (K Units) Table 50. Europe Valsartan-Hydrochlorothiazide Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Valsartan-Hydrochlorothiazide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Valsartan-Hydrochlorothiazide Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Valsartan-Hydrochlorothiazide Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Valsartan-Hydrochlorothiazide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Valsartan-Hydrochlorothiazide Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Valsartan-Hydrochlorothiazide Sales by Country (2027-2032) & (K Units) Table 57. Global Valsartan-Hydrochlorothiazide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Valsartan-Hydrochlorothiazide Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Valsartan-Hydrochlorothiazide Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Region (2021-2026) Table 61. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Region (2027-2032) Table 62. Teva Company Information Table 63. Teva Business Overview Table 64. Teva Valsartan-Hydrochlorothiazide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Teva Valsartan-Hydrochlorothiazide Product Portfolio Table 66. Teva Recent Development Table 67. Novartis Company Information Table 68. Novartis Business Overview Table 69. Novartis Valsartan-Hydrochlorothiazide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Novartis Valsartan-Hydrochlorothiazide Product Portfolio Table 71. Novartis Recent Development Table 72. Mylan Company Information Table 73. Mylan Business Overview Table 74. Mylan Valsartan-Hydrochlorothiazide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Mylan Valsartan-Hydrochlorothiazide Product Portfolio Table 76. Mylan Recent Development Table 77. Huaren Pharmaceutical Company Information Table 78. Huaren Pharmaceutical Business Overview Table 79. Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio Table 81. Huaren Pharmaceutical Recent Development Table 82. Zhejiang Huahai Pharmaceutical Company Information Table 83. Zhejiang Huahai Pharmaceutical Business Overview Table 84. Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio Table 86. Zhejiang Huahai Pharmaceutical Recent Development Table 87. Torrent Pharmaceuticals Company Information Table 88. Torrent Pharmaceuticals Business Overview Table 89. Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Product Portfolio Table 91. Torrent Pharmaceuticals Recent Development Table 92. Par Pharmaceutical Company Information Table 93. Par Pharmaceutical Business Overview Table 94. Par Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Par Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio Table 96. Par Pharmaceutical Recent Development Table 97. MACLEODS Company Information Table 98. MACLEODS Business Overview Table 99. MACLEODS Valsartan-Hydrochlorothiazide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. MACLEODS Valsartan-Hydrochlorothiazide Product Portfolio Table 101. MACLEODS Recent Development Table 102. Lupin Company Information Table 103. Lupin Business Overview Table 104. Lupin Valsartan-Hydrochlorothiazide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Lupin Valsartan-Hydrochlorothiazide Product Portfolio Table 106. Lupin Recent Development Table 107. Cisen Pharmaceutical Company Information Table 108. Cisen Pharmaceutical Business Overview Table 109. Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio Table 111. Cisen Pharmaceutical Recent Development Table 112. Chongqing Conquer Pharmaceutical Company Information Table 113. Chongqing Conquer Pharmaceutical Business Overview Table 114. Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio Table 116. Chongqing Conquer Pharmaceutical Recent Development Table 117. Beijing Second Pharmaceutical Company Information Table 118. Beijing Second Pharmaceutical Business Overview Table 119. Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio Table 121. Beijing Second Pharmaceutical Recent Development Table 122. Aurobindo Pharma Company Information Table 123. Aurobindo Pharma Business Overview Table 124. Aurobindo Pharma Valsartan-Hydrochlorothiazide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Aurobindo Pharma Valsartan-Hydrochlorothiazide Product Portfolio Table 126. Aurobindo Pharma Recent Development Table 127. APOTEX Company Information Table 128. APOTEX Business Overview Table 129. APOTEX Valsartan-Hydrochlorothiazide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. APOTEX Valsartan-Hydrochlorothiazide Product Portfolio Table 131. APOTEX Recent Development Table 132. Alembic Pharmaceuticals Company Information Table 133. Alembic Pharmaceuticals Business Overview Table 134. Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Product Portfolio Table 136. Alembic Pharmaceuticals Recent Development Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Valsartan-Hydrochlorothiazide Distributors List Table 140. Valsartan-Hydrochlorothiazide Customers List Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Valsartan-Hydrochlorothiazide Product Image Figure 2. Global Valsartan-Hydrochlorothiazide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valsartan-Hydrochlorothiazide Market Size (2021-2032) & (US$ Million) Figure 4. Global Valsartan-Hydrochlorothiazide Sales (2021-2032) & (K Units) Figure 5. Global Valsartan-Hydrochlorothiazide Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Valsartan-Hydrochlorothiazide Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablet Image Figure 9. Capsule Image Figure 10. Global Valsartan-Hydrochlorothiazide Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Valsartan-Hydrochlorothiazide Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Valsartan-Hydrochlorothiazide Sales Market Share by Type (2021-2032) Figure 13. Global Valsartan-Hydrochlorothiazide Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Valsartan-Hydrochlorothiazide Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Drug Store Image Figure 18. Global Valsartan-Hydrochlorothiazide Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Valsartan-Hydrochlorothiazide Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Valsartan-Hydrochlorothiazide Sales Market Share by Application (2021-2032) Figure 21. Global Valsartan-Hydrochlorothiazide Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Valsartan-Hydrochlorothiazide Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Application (2021-2032) Figure 24. North America Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Valsartan-Hydrochlorothiazide Sales Market Share by Country (2021-2032) Figure 26. U.S. Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Valsartan-Hydrochlorothiazide Sales Market Share by Country (2021-2032) Figure 31. Germany Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Valsartan-Hydrochlorothiazide Sales Market Share by Country (2021-2032) Figure 38. China Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Valsartan-Hydrochlorothiazide Sales Market Share by Country (2021-2032) Figure 46. Brazil Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Valsartan-Hydrochlorothiazide Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Valsartan-Hydrochlorothiazide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Valsartan-Hydrochlorothiazide Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Valsartan-Hydrochlorothiazide Revenue (2021-2032) & (US$ Million) Figure 57. North America Valsartan-Hydrochlorothiazide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Valsartan-Hydrochlorothiazide Revenue (2021-2032) & (US$ Million) Figure 59. Europe Valsartan-Hydrochlorothiazide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Valsartan-Hydrochlorothiazide Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Valsartan-Hydrochlorothiazide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Valsartan-Hydrochlorothiazide Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Valsartan-Hydrochlorothiazide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Valsartan-Hydrochlorothiazide Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Valsartan-Hydrochlorothiazide Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
Applications
  • Hospital
  • Drug Store
Companies covered
  • Teva
  • Novartis
  • Mylan
  • Huaren Pharmaceutical
  • Zhejiang Huahai Pharmaceutical
  • Torrent Pharmaceuticals
  • Par Pharmaceutical
  • MACLEODS
  • Lupin
  • Cisen Pharmaceutical
  • Chongqing Conquer Pharmaceutical
  • Beijing Second Pharmaceutical
  • Aurobindo Pharma
  • APOTEX
  • Alembic Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Valsartan-Hydrochlorothiazide Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Valsartan-Hydrochlorothiazide Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Valsartan-Hydrochlorothiazide Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Valsartan-Hydrochlorothiazide Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Valsartan-Hydrochlorothiazide Market Dynamics
  1. 2.1 Valsartan-Hydrochlorothiazide Industry Trends
  2. 2.2 Valsartan-Hydrochlorothiazide Industry Drivers
  3. 2.3 Valsartan-Hydrochlorothiazide Industry Opportunities and Challenges
  4. 2.4 Valsartan-Hydrochlorothiazide Industry Restraints
3 Valsartan-Hydrochlorothiazide Market by Manufacturers
  1. 3.1 Global Valsartan-Hydrochlorothiazide Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Valsartan-Hydrochlorothiazide Sales by Manufacturers (2021-2026)
  3. 3.3 Global Valsartan-Hydrochlorothiazide Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Valsartan-Hydrochlorothiazide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Valsartan-Hydrochlorothiazide Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Valsartan-Hydrochlorothiazide Manufacturers, Product Type & Application
  7. 3.7 Global Valsartan-Hydrochlorothiazide Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Valsartan-Hydrochlorothiazide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Valsartan-Hydrochlorothiazide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Valsartan-Hydrochlorothiazide Tier 1, Tier 2, and Tier 3
4 Valsartan-Hydrochlorothiazide Market by Type
  1. 4.1 Valsartan-Hydrochlorothiazide Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Capsule
  4. 4.2 Global Valsartan-Hydrochlorothiazide Sales by Type
  5. 4.2.1 Global Valsartan-Hydrochlorothiazide Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Valsartan-Hydrochlorothiazide Sales by Type (2021-2032)
  7. 4.2.3 Global Valsartan-Hydrochlorothiazide Sales Market Share by Type (2021-2032)
  8. 4.3 Global Valsartan-Hydrochlorothiazide Revenue by Type
  9. 4.3.1 Global Valsartan-Hydrochlorothiazide Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Valsartan-Hydrochlorothiazide Revenue by Type (2021-2032)
  11. 4.3.3 Global Valsartan-Hydrochlorothiazide Revenue Market Share by Type (2021-2032)
5 Valsartan-Hydrochlorothiazide Market by Application
  1. 5.1 Valsartan-Hydrochlorothiazide Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.2 Global Valsartan-Hydrochlorothiazide Sales by Application
  5. 5.2.1 Global Valsartan-Hydrochlorothiazide Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Valsartan-Hydrochlorothiazide Sales by Application (2021-2032)
  7. 5.2.3 Global Valsartan-Hydrochlorothiazide Sales Market Share by Application (2021-2032)
  8. 5.3 Global Valsartan-Hydrochlorothiazide Revenue by Application
  9. 5.3.1 Global Valsartan-Hydrochlorothiazide Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Valsartan-Hydrochlorothiazide Revenue by Application (2021-2032)
  11. 5.3.3 Global Valsartan-Hydrochlorothiazide Revenue Market Share by Application (2021-2032)
6 Global Valsartan-Hydrochlorothiazide Sales by Region
  1. 6.1 Global Valsartan-Hydrochlorothiazide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Valsartan-Hydrochlorothiazide Sales by Region (2021-2032)
  3. 6.2.1 Global Valsartan-Hydrochlorothiazide Sales by Region (2021-2026)
  4. 6.2.2 Global Valsartan-Hydrochlorothiazide Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Valsartan-Hydrochlorothiazide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Valsartan-Hydrochlorothiazide Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Valsartan-Hydrochlorothiazide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Valsartan-Hydrochlorothiazide Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Valsartan-Hydrochlorothiazide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Valsartan-Hydrochlorothiazide Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Valsartan-Hydrochlorothiazide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Valsartan-Hydrochlorothiazide Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Valsartan-Hydrochlorothiazide Revenue by Region
  1. 7.1 Global Valsartan-Hydrochlorothiazide Revenue by Region
  2. 7.1.1 Global Valsartan-Hydrochlorothiazide Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Valsartan-Hydrochlorothiazide Revenue by Region (2021-2026)
  4. 7.1.3 Global Valsartan-Hydrochlorothiazide Revenue by Region (2027-2032)
  5. 7.1.4 Global Valsartan-Hydrochlorothiazide Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Valsartan-Hydrochlorothiazide Revenue (2021-2032)
  8. 7.2.2 North America Valsartan-Hydrochlorothiazide Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Valsartan-Hydrochlorothiazide Revenue (2021-2032)
  11. 7.3.2 Europe Valsartan-Hydrochlorothiazide Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Valsartan-Hydrochlorothiazide Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Valsartan-Hydrochlorothiazide Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Valsartan-Hydrochlorothiazide Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Valsartan-Hydrochlorothiazide Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Valsartan-Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Valsartan-Hydrochlorothiazide Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Valsartan-Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Valsartan-Hydrochlorothiazide Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Valsartan-Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Valsartan-Hydrochlorothiazide Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Huaren Pharmaceutical
  20. 8.4.1 Huaren Pharmaceutical Company Information
  21. 8.4.2 Huaren Pharmaceutical Business Overview
  22. 8.4.3 Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
  24. 8.4.5 Huaren Pharmaceutical Recent Developments
  25. 8.5 Zhejiang Huahai Pharmaceutical
  26. 8.5.1 Zhejiang Huahai Pharmaceutical Company Information
  27. 8.5.2 Zhejiang Huahai Pharmaceutical Business Overview
  28. 8.5.3 Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
  30. 8.5.5 Zhejiang Huahai Pharmaceutical Recent Developments
  31. 8.6 Torrent Pharmaceuticals
  32. 8.6.1 Torrent Pharmaceuticals Company Information
  33. 8.6.2 Torrent Pharmaceuticals Business Overview
  34. 8.6.3 Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Product Portfolio
  36. 8.6.5 Torrent Pharmaceuticals Recent Developments
  37. 8.7 Par Pharmaceutical
  38. 8.7.1 Par Pharmaceutical Company Information
  39. 8.7.2 Par Pharmaceutical Business Overview
  40. 8.7.3 Par Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Par Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
  42. 8.7.5 Par Pharmaceutical Recent Developments
  43. 8.8 MACLEODS
  44. 8.8.1 MACLEODS Company Information
  45. 8.8.2 MACLEODS Business Overview
  46. 8.8.3 MACLEODS Valsartan-Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 MACLEODS Valsartan-Hydrochlorothiazide Product Portfolio
  48. 8.8.5 MACLEODS Recent Developments
  49. 8.9 Lupin
  50. 8.9.1 Lupin Company Information
  51. 8.9.2 Lupin Business Overview
  52. 8.9.3 Lupin Valsartan-Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lupin Valsartan-Hydrochlorothiazide Product Portfolio
  54. 8.9.5 Lupin Recent Developments
  55. 8.10 Cisen Pharmaceutical
  56. 8.10.1 Cisen Pharmaceutical Company Information
  57. 8.10.2 Cisen Pharmaceutical Business Overview
  58. 8.10.3 Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
  60. 8.10.5 Cisen Pharmaceutical Recent Developments
  61. 8.11 Chongqing Conquer Pharmaceutical
  62. 8.11.1 Chongqing Conquer Pharmaceutical Company Information
  63. 8.11.2 Chongqing Conquer Pharmaceutical Business Overview
  64. 8.11.3 Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
  66. 8.11.5 Chongqing Conquer Pharmaceutical Recent Developments
  67. 8.12 Beijing Second Pharmaceutical
  68. 8.12.1 Beijing Second Pharmaceutical Company Information
  69. 8.12.2 Beijing Second Pharmaceutical Business Overview
  70. 8.12.3 Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
  72. 8.12.5 Beijing Second Pharmaceutical Recent Developments
  73. 8.13 Aurobindo Pharma
  74. 8.13.1 Aurobindo Pharma Company Information
  75. 8.13.2 Aurobindo Pharma Business Overview
  76. 8.13.3 Aurobindo Pharma Valsartan-Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Aurobindo Pharma Valsartan-Hydrochlorothiazide Product Portfolio
  78. 8.13.5 Aurobindo Pharma Recent Developments
  79. 8.14 APOTEX
  80. 8.14.1 APOTEX Company Information
  81. 8.14.2 APOTEX Business Overview
  82. 8.14.3 APOTEX Valsartan-Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 APOTEX Valsartan-Hydrochlorothiazide Product Portfolio
  84. 8.14.5 APOTEX Recent Developments
  85. 8.15 Alembic Pharmaceuticals
  86. 8.15.1 Alembic Pharmaceuticals Company Information
  87. 8.15.2 Alembic Pharmaceuticals Business Overview
  88. 8.15.3 Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Product Portfolio
  90. 8.15.5 Alembic Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Valsartan-Hydrochlorothiazide Value Chain Analysis
  2. 9.1.1 Valsartan-Hydrochlorothiazide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Valsartan-Hydrochlorothiazide Production Mode & Process
  6. 9.2 Valsartan-Hydrochlorothiazide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Valsartan-Hydrochlorothiazide Distributors
  9. 9.2.3 Valsartan-Hydrochlorothiazide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst